2006Northwest Pharmaceutical JournalRequires access

Bioequivalence of levofloxacin tablets in healthy volunteers

Jiangping Lian

Open publisher page 0 citations

Abstract

Objective To evaluate the relative bioavailability and bioequivalence of levofloxacin tablets. Methods 18 male healthy volunteers orally took a single dose of 200mg tablets in randamized self-crossover ways .The plasma concentrations of levofloxacin were determined by RP-HPLC with fluorescent detector. Results The pharmacokinetic parameters of levofloxacin reference and test drug were as follows : t_ max (0.99±0.31) and (1.01±0.57) h;C_ max (1.73±0.50) and (1.68±0.39) μg·mL~ -1 ;t_ 1/2β (6.99±1.00) and (6.71±1.10) h;MRT (9.62±1.58) and (9.44±1.47) h; AUC_ (0→24) (12.46±1.69) and (12.05±1.75) μg·h·mL~ -1 , respectively .There was no statistical difference between the reference and the test levofloxacin tablet in pharmacokinetic parameters(P0.05).The relative bioavailability of levofloxacin tablet was (103.80±6.10)%. Conclusion The reference and the test levofloxacin tablets are bioequivalent.

About this research paper

What this paper is about

Objective To evaluate the relative bioavailability and bioequivalence of levofloxacin tablets. Methods 18 male healthy volunteers orally took a single dose of 200mg tablets in randamized self-crossover ways .The plasma concentrations of levofloxacin were determined by RP-HPLC with fluorescent detector. Results The pharmacokinetic parameters of levofloxacin reference and test drug were as follows : t_ max (0.99±0.31) and (1.01±0.57) h;C_ max (1.73±0.50) and (1.68±0.39) μg·mL~ -1 ;t_ 1/2β (6.99±1.00) and (6.71±1.10) h;MRT (9.62±1.58) and (9.44±1.47) h; AUC_ (0→24) (12.46±1.69) and (12.05±1.75) μg·h·mL~ -1 , respectively .There was no statistical difference between the reference and the test levofloxacin tablet in pharmacokinetic parameters(P0.05).The relative bioavailability of levofloxacin tablet was (103.80±6.10)%. Conclusion The reference and the test levofloxacin tablets are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the relative bioavailability and bioequivalence of levofloxacin tablets. Methods 18 male healthy volunteers orally took a single dose of 200mg tablets in randamized self-crossover ways .The plasma concentrations of levofloxacin were determined by RP-HPLC with fluorescent detector. Results The pharmacokinetic parameters of levofloxacin reference and test drug were as follows : t_ max (0.99±0.31) and (1.01±0.57) h;C_ max (1.73±0.50) and (1.68±0.39) μg·mL~ -1 ;t_ 1/2β (6.99±1.00) and (6.71±1.10) h;MRT (9.62±1.58) and (9.44±1.47) h; AUC_ (0→24) (12.46±1.69) and (12.05±1.75) μg·h·mL~ -1 , respectively .There was no statistical difference between the reference and the test levofloxacin tablet in pharmacokinetic parameters(P0.05).The relative bioavailability of levofloxacin tablet was (103.80±6.10)%. Conclusion The reference and the test levofloxacin tablets are bioequivalent.

Key concepts: Bioequivalence, Levofloxacin, Bioavailability, Pharmacokinetics, Pharmacology, Crossover study, High-performance liquid chromatography, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of levofloxacin tablets in healthy volunteers — Research Paper | ScholarLens